Zai Lab Limited (9688.HK)

HKD 20.5

(-3.76%)

Total Liabilities Summary of Zai Lab Limited

Zai Lab Limited's latest annual total liabilities in 2023 was 240.17 Million USD , up 37.6% from previous year.
Zai Lab Limited's latest quarterly total liabilities in 2024 Q1 was 226.26 Million USD , down -5.79% from previous quarter.
Zai Lab Limited reported annual total liabilities of 174.54 Million USD in 2022, down -24.11% from previous year.
Zai Lab Limited reported annual total liabilities of 230 Million USD in 2021, up 79.28% from previous year.
Zai Lab Limited reported quarterly total liabilities of 283.18 Million USD for 2024 Q2, up 25.16% from previous quarter.
Zai Lab Limited reported quarterly total liabilities of 174.05 Million USD for 2023 Q2, up 3.1% from previous quarter.

Annual Total Liabilities Chart of Zai Lab Limited (2023 - 2015)

Historical Annual Total Liabilities of Zai Lab Limited (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	240.17 Million USD	37.6%
2022	174.54 Million USD	-24.11%
2021	230 Million USD	79.28%
2020	128.29 Million USD	112.08%
2019	60.49 Million USD	18.83%
2018	50.9 Million USD	251.96%
2017	14.46 Million USD	-89.7%
2016	140.45 Million USD	334.73%
2015	32.3 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	226.26 Million USD	-5.79%
2024 Q2	283.18 Million USD	25.16%
2023 Q2	174.05 Million USD	3.1%
2023 FY	240.17 Million USD	37.6%
2023 Q4	240.17 Million USD	47.61%
2023 Q3	162.71 Million USD	-6.52%
2023 Q1	168.83 Million USD	-3.27%
2022 Q1	192.9 Million USD	-16.13%
2022 FY	174.54 Million USD	-24.11%
2022 Q4	174.54 Million USD	-9.4%
2022 Q3	192.64 Million USD	-6.76%
2022 Q2	206.61 Million USD	7.1%
2021 Q1	121.62 Million USD	-5.2%
2021 Q2	223.51 Million USD	83.78%
2021 Q3	140.14 Million USD	-37.3%
2021 Q4	230 Million USD	64.11%
2021 FY	230 Million USD	79.28%
2020 Q4	128.29 Million USD	0.0%
2020 Q2	82.74 Million USD	0.0%
2020 Q1	- USD	-100.0%
2020 FY	128.29 Million USD	112.08%
2019 Q3	54.51 Million USD	2.61%
2019 Q4	60.49 Million USD	10.97%
2019 Q2	53.13 Million USD	0.0%
2019 FY	60.49 Million USD	18.83%
2019 Q1	53.13 Million USD	4.37%
2018 Q4	50.9 Million USD	0.0%
2018 FY	50.9 Million USD	251.96%
2018 Q2	11.88 Million USD	15.81%
2018 Q1	10.25 Million USD	-29.07%
2017 Q2	175.01 Million USD	1717.45%
2017 Q3	12.06 Million USD	-93.1%
2017 Q4	14.46 Million USD	19.84%
2017 FY	14.46 Million USD	-89.7%
2017 Q1	9.62 Million USD	-93.14%
2016 Q1	- USD	0.0%
2016 Q3	5.17 Million USD	0.0%
2016 Q4	140.45 Million USD	2614.99%
2016 FY	140.45 Million USD	334.73%
2015 FY	32.3 Million USD	0.0%

Peer Total Liabilities Comparison of Zai Lab Limited

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-57.165%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	96.597%